Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Virpax Pharmaceuticals Inc
(NQ:
VRPX
)
0.7200
UNCHANGED
Streaming Delayed Price
Updated: 3:58 PM EDT, May 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,319
Open
0.7200
Bid (Size)
0.6803 (12)
Ask (Size)
0.7090 (1)
Prev. Close
0.7200
Today's Range
0.7200 - 0.7200
52wk Range
0.2402 - 5.480
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Urban Outfitters Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
May 22, 2024
Via
Benzinga
Gold Rises Over 1%; Arcos Dorados Shares Fall After Q1 Results
May 15, 2024
Via
Benzinga
Performance
YTD
+125.71%
+125.71%
1 Month
-77.22%
-77.22%
3 Month
+132.11%
+132.11%
6 Month
+37.75%
+37.75%
1 Year
-8.28%
-8.28%
More News
Read More
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 15, 2024
Via
Benzinga
Nasdaq Surges 150 Points; Retail Sales Flat For April
May 15, 2024
Via
Benzinga
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 15, 2024
Via
Benzinga
Dow Jumps 200 Points; US Inflation Rate Slows In April
May 15, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Castellum (CTM) Stock Down 16% Today?
May 15, 2024
Via
InvestorPlace
Why Is Virpax Pharmaceuticals (VRPX) Stock Down 61% Today?
May 15, 2024
Via
InvestorPlace
Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
May 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 15, 2024
Via
Benzinga
Virpax Announces Pricing of $2.25 Million Public Offering
May 15, 2024
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 15, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 14, 2024
Via
Benzinga
VRPX Stock Earnings: Virpax Pharmaceuticals Reported Results for Q1 2024
May 13, 2024
Via
InvestorPlace
Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments
May 13, 2024
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™
April 30, 2024
From
Virpax Pharmaceuticals
Via
Business Wire
VRPX Stock Earnings: Virpax Pharmaceuticals Misses EPS for Q4 2023
April 24, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
April 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 26, 2024
Via
Benzinga
Virpax Pharmaceuticals Reports 2023 Year-End Results
March 26, 2024
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 19, 2024
Via
Benzinga
Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
February 27, 2024
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.
February 27, 2024
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 21, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.